These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38364800)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incorporating ethics and welfare into randomized experiments.
    Narita Y
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size considerations for comparing dynamic treatment regimens in a sequential multiple-assignment randomized trial with a continuous longitudinal outcome.
    Seewald NJ; Kidwell KM; Nahum-Shani I; Wu T; McKay JR; Almirall D
    Stat Methods Med Res; 2020 Jul; 29(7):1891-1912. PubMed ID: 31571526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy.
    Almirall D; Compton SN; Gunlicks-Stoessel M; Duan N; Murphy SA
    Stat Med; 2012 Jul; 31(17):1887-902. PubMed ID: 22438190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: An application in focal segmental glomerulosclerosis.
    Chao YC; Trachtman H; Gipson DS; Spino C; Braun TM; Kidwell KM
    Contemp Clin Trials; 2020 May; 92():105989. PubMed ID: 32200006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Sequential Multiple Assignment Randomized Trials (SMARTs) in oncology: systematic review of published studies.
    Lorenzoni G; Petracci E; Scarpi E; Baldi I; Gregori D; Nanni O
    Br J Cancer; 2023 Mar; 128(7):1177-1188. PubMed ID: 36572731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiple imputation strategy for sequential multiple assignment randomized trials.
    Shortreed SM; Laber E; Scott Stroup T; Pineau J; Murphy SA
    Stat Med; 2014 Oct; 33(24):4202-14. PubMed ID: 24919867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative incidence regression for dynamic treatment regimens.
    Chen LW; Yavuz I; Cheng Y; Wahed AS
    Biostatistics; 2020 Apr; 21(2):e113-e130. PubMed ID: 30371745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS).
    Evans SR; Follmann D; Liu Y; Holland T; Doernberg SB; Rouphael N; Hamasaki T; Jiang Y; Lok JJ; Tran TTT; Harris AD; Fowler VG; Boucher H; Kreiswirth BN; Bonomo RA; Van Duin D; Paterson DL; Chambers H
    Clin Infect Dis; 2019 May; 68(11):1961-1967. PubMed ID: 30351426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LIBERTI: A SMART study in plastic surgery.
    Hibbard JC; Friedstat JS; Thomas SM; Edkins RE; Hultman CS; Kosorok MR
    Clin Trials; 2018 Jun; 15(3):286-293. PubMed ID: 29577741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-varying SMART design and data analysis methods for evaluating adaptive intervention effects.
    Dai T; Shete S
    BMC Med Res Methodol; 2016 Aug; 16(1):112. PubMed ID: 27578254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMARTer discontinuation trial designs for developing an adaptive treatment strategy.
    Almirall D; Compton SN; Rynn MA; Walkup JT; Murphy SA
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):364-74. PubMed ID: 23083023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case study of SMART attributes: a qualitative assessment of generalizability, retention rate, and trial quality.
    Moodie EE; Karran JC; Shortreed SM
    Trials; 2016 May; 17(1):242. PubMed ID: 27180047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel approach to assess dynamic treatment regimes embedded in a SMART with an ordinal outcome.
    Ghosh P; Yan X; Chakraborty B
    Stat Med; 2023 Mar; 42(7):1096-1111. PubMed ID: 36726310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Get SMART - Understanding Sequential Multiple Assignment Randomized Trials.
    Kim HM
    NEJM Evid; 2023 Apr; 2(4):EVIDe2300031. PubMed ID: 38320015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations.
    NeCamp T; Kilbourne A; Almirall D
    Stat Methods Med Res; 2017 Aug; 26(4):1572-1589. PubMed ID: 28627310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal allocation to treatments in a sequential multiple assignment randomized trial.
    Morciano A; Moerbeek M
    Stat Methods Med Res; 2021 Nov; 30(11):2471-2484. PubMed ID: 34554015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A SMART design to optimize treatment strategies for patient and family caregiver outcomes.
    Song MK; DeVito Dabbs A; Ward SE
    Nurs Outlook; 2016; 64(4):299-305. PubMed ID: 27264454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.